Zollinger-Ellison syndrome other imaging findings: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Mohamad Alkateb (talk | contribs)
nocaptcha
1,628 edits
Mohamad Alkateb (talk | contribs)
nocaptcha
1,628 edits
Line 12: Line 12:
SRS1.jpg|37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 4 hours.Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
SRS1.jpg|37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 4 hours.Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
SRS2.jpg|37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 24 hours. Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
SRS2.jpg|37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 24 hours. Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
SRS3.jpg|Axial scan at 24 hours.
SRS3.jpg|Axial scan at 24 hours.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
SRS4.jpg|Coronal scan at 24 hours.
SRS4.jpg|Coronal scan at 24 hours.<ref>{{cite journal|doi=10.2484/rcr.v514.452}}</ref>
</gallery>
</gallery>


Revision as of 22:57, 1 October 2015

Zollinger-Ellison syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Zollinger-Ellison syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zollinger-Ellison syndrome other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zollinger-Ellison syndrome other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zollinger-Ellison syndrome other imaging findings

CDC on Zollinger-Ellison syndrome other imaging findings

Zollinger-Ellison syndrome other imaging findings in the news

Blogs on Zollinger-Ellison syndrome other imaging findings

Directions to Hospitals Treating Zollinger-Ellison syndrome

Risk calculators and risk factors for Zollinger-Ellison syndrome other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Endoscopic ultrasound and Somatostatin receptor scintigraphy (SRS) (octreotide scan) may be helpful in the diagnosis of Zollinger-Ellison syndrome caused by gastrinoma.[1]

Other Imaging Findings

Other imaging studies that may be helpful in the diagnosis of Zollinger-Ellison syndrome include:

Gallery

  • 37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 4 hours.Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.[3]
    37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 4 hours.Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.[3]
  • 37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 24 hours. Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.[4]
    37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 24 hours. Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.[4]
  • Axial scan at 24 hours.[5]
    Axial scan at 24 hours.[5]
  • Coronal scan at 24 hours.[6]
    Coronal scan at 24 hours.[6]

References

  1. ↑ 1.0 1.1 Tang, Shou-jiang; Wu, Ruonan; Bhaijee, Feriyl (2014). "Zollinger–Ellison Syndrome". Video Journal and Encyclopedia of GI Endoscopy. 1 (3–4): 666–668. doi:10.1016/j.vjgien.2013.06.005. ISSN 2212-0971.
  2. ↑ Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D; et al. (1997). "Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)". Gut. 41 (1): 107–14. PMC 1027237. PMID 9274481.
  3. ↑ . doi:10.2484/rcr.v514.452. Missing or empty |title= (help)
  4. ↑ . doi:10.2484/rcr.v514.452. Missing or empty |title= (help)
  5. ↑ . doi:10.2484/rcr.v514.452. Missing or empty |title= (help)
  6. ↑ . doi:10.2484/rcr.v514.452. Missing or empty |title= (help)

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Zollinger-Ellison_syndrome_other_imaging_findings&oldid=1167279"